P381 Predictors and frequency of anti-TNF dose escalation in patients with inflammatory bowel disease by Viazis, N., Koukouratos, T., Anastasiou, J., Saprikis, E., Kechagias, G., Katopodi, K., Mela, M., Karamanolis, D.

Get full text

DOP085 Success rate of dose de-escalation in patients with inflammatory bowel disease treated with intensified anti-TNF therapy by Viazis, N., Anastasiou, J., Koukouratos, T., Giakoumis, M., Anastasopoulos, E., Chanias, M., Markoglou, K., Karamanolis, D.

Get full text

P489 How often is dose escalation needed in patients with inflammatory bowel disease treated with anti-TNF? by Viazis, N., Koukouratos, T., Saprikis, E., Al-Odat, M., Anastasopoulos, E., Zacharakis, G., Karamanolis, D.

Get full text

P604 Prevalence and characteristics of dermatologic manifestations in a Greek population of inflammatory bowel disease patients followed-up in tertiary centers by Karmiris, K., Avgerinos, A., Tavernaraki, A., Mantzaris, G.I., Koukouratos, T., Oikonomou, K., Kostas, A., Viazis, N., Kapsoritakis, A., Bamias, G., Theodoropoulou, A., Karamanolis, D.G., Koutroubakis, I.E.

Get full text

P603 Prevalence and characteristics of extra-intestinal manifestations in a Greek population of inflammatory bowel disease patients followed-up in tertiary centers by Karmiris, K., Avgerinos, A., Tavernaraki, A., Mantzaris, G.I., Koukouratos, T., Oikonomou, K., Kostas, A., Viazis, N., Kapsoritakis, A., Bamias, G., Theodoropoulou, A., Karamanolis, D.G., Koutroubakis, I.E.

Get full text

P105 A single center experience with small bowel capsule endoscopy for patients with established Crohn's disease: When is it safe? by Viazis, N., Giakoumis, M., Koukouratos, T., Anastasopoulos, E., Kechagias, G., Katopodi, K., Karamanolis, D.

Get full text

Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease by Karmiris, Konstantinos, Avgerinos, Anastasios, Tavernaraki, Aikaterini, Zeglinas, Christos, Karatzas, Pantelis, Koukouratos, Theodoros, Oikonomou, Konstantinos A., Kostas, Athanasios, Zampeli, Evanthia, Papadopoulos, Vasileios, Theodoropoulou, Angeliki, Viazis, Nikos, Polymeros, Dimitrios, Michopoulos, Spyridon, Bamias, Giorgos, Kapsoritakis, Andreas, Karamanolis, Dimitrios G., Mantzaris, Gerassimos J., Tzathas, Charalampos, Koutroubakis, Ioannis E.

Get full text

Long term benefit of one year infliximab administration for the treatment of chronic refractory pouchitis by Viazis, Nikos, Giakoumis, Marios, Koukouratos, Theodoros, Anastasiou, Jiannis, Katopodi, Konstantina, Kechagias, Georgios, Anastasopoulos, Elias, Saprikis, Efstathios, Chanias, Michail, Tribonias, George, Karamanolis, Dimitrios G.

Get full text

Predictors of tissue healing in ulcerative colitis patients treated with anti-TNF by Viazis, Nikos, Giakoumis, Marios, Bamias, Giorgos, Goukos, Dimitris, Koukouratos, Theodoros, Katopodi, Konstantina, Karatzas, Pantelis, Triantos, Christos, Tsolias, Chrisostomos, Theocharis, Georgios, Daikos, George L, Ladas, Spyros D, Karamanolis, Dimitrios G, Mantzaris, Gerasimos J

Get full text

One-year infliximab administration for the treatment of chronic refractory pouchitis by Viazis, Nikos, Giakoumis, Marios, Koukouratos, Theodoros, Saprikis, Efstathios, Anastasopoulos, Elias, Al-Odat, Mousa, Kechagias, Georgios, Zacharakis, Georgios, Markoglou, Konstantinos, Gouma, Paraskevi, Karamanolis, Demetrios G

Get full text